Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression (2021)
Silveira, Kennia Moura; Wegener, Gregers; Wegener, Sâmia Regiane Lourenço Joca 
Source: Basic & Clinical Pharmacology & Toxicology. Unidade: FCFRP
Subjects: ANTIDEPRESSIVOS, ÁCIDOS ARAQUIDÔNICOS, CÉREBRO, DEPRESSÃO, GLICERÍDEOS, CANABINOIDES, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Kennia Moura e WEGENER, Gregers e WEGENER, Sâmia Regiane Lourenço Joca. Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression. Basic & Clinical Pharmacology & Toxicology, v. 129, n. 1, p. 3-14, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13595. Acesso em: 21 abr. 2026.APA
Silveira, K. M., Wegener, G., & Wegener, S. R. L. J. (2021). Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression. Basic & Clinical Pharmacology & Toxicology, 129( 1), 3-14. doi:10.1111/bcpt.13595NLM
Silveira KM, Wegener G, Wegener SRLJ. Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 129( 1): 3-14.[citado 2026 abr. 21 ] Available from: https://doi.org/10.1111/bcpt.13595Vancouver
Silveira KM, Wegener G, Wegener SRLJ. Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 129( 1): 3-14.[citado 2026 abr. 21 ] Available from: https://doi.org/10.1111/bcpt.13595
